CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-06 | Bazemore Todd SEE REMARKS | Grant or award | +10,100 | |||
| 2025-01-06 | Bazemore Todd SEE REMARKS | Sale | −1,993 | $7.63 | $15K | |
| 2025-01-06 | Bazemore Todd SEE REMARKS | Grant or award · Stock Option (right to buy) | +45,200 | 45,200 | ||
| 2025-01-06 | Brazzell Romulus K SEE REMARKS | Grant or award | +10,100 | 94,864 | ||
| 2025-01-06 | Brazzell Romulus K SEE REMARKS | Sale | −2,446 | $7.63 | $19K | 92,418 |
| 2025-01-06 | Brazzell Romulus K SEE REMARKS | Grant or award · Stock Option (right to buy) | +45,200 | 45,200 | ||
| 2025-01-06 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award | +22,100 | 285,855 | ||
| 2025-01-06 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Sale | −5,779 | $7.63 | $44K | 280,076 |
| 2025-01-06 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +99,500 | 99,500 | ||
| 2025-01-06 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award | +10,100 | 70,287 | ||
| 2025-01-06 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −1,706 | $7.63 | $13K | 68,581 |
| 2025-01-06 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +45,200 | 45,200 | ||
| 2024-12-30 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +30,620 | $6.44 | $197K | 118,496 |
| 2024-12-30 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +279,939 | $6.44 | $1.8M | 1,083,398 |
| 2024-06-26 | Bazemore Todd SEE REMARKS | Sale | −4,653 | $4.75 | $22K | 83,040 |
| 2024-06-26 | Kharabi Darius CHIEF BUSINESS OFFICER | Sale | −5,158 | $4.75 | $25K | 59,728 |
| 2024-06-26 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −4,163 | $4.75 | $20K | 60,187 |
| 2024-06-26 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Sale | −15,168 | $4.75 | $72K | 263,755 |
| 2024-06-26 | Brazzell Romulus K SEE REMARKS | Sale | −5,489 | $4.75 | $26K | 83,982 |
| 2024-06-11 | Rosen Howard B Director | Grant or award | +1,400 | 13,887 |
Page 3 of 12 · 236 trades